CRL 250417 180.00P(CRL250417P180000) Stock Price Today

US OptionsDetailed Quotes

CRL250417P180000

Watchlist

46.70
+26.10+126.70%

15min DelayTrading Apr 7 13:47 ET

46.70High46.70Low

Intraday

5D
Daily

News

Charles River Laboratories International Inc. Stock Slides 3.0%, Underperforms Market
Dow JonesApr 1 16:35 ET
The Three-year Earnings Decline Is Not Helping Charles River Laboratories International's (NYSE:CRL Share Price, as Stock Falls Another 9.9% in Past Week
Simply Wall StApr 1 11:42 ET
The FDA Is 'Finished' as Firings Sweep Health Agencies. Drug Stocks Are Falling. -- Barrons.com
Barron'sApr 1 10:19 ET
The "Liberation Day" of Trump's tariffs is approaching, and the pharmaceutical Industry may not be among the targets.
According to reports, President Trump of the USA is expected to announce a series of broader tariff measures on local time April 2 (Wednesday), which will not include any specific details on Pharmaceutical tariffs.
Zhitong FinanceApr 1 08:50 ET
Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease
PR NewswireApr 1 08:00 ET
Baird Adjusts Charles River Laboratories International Price Target to $155 From $173, Maintains Neutral Rating
MT NewswiresMar 31 10:27 ET · Ratings

Comments

韭菜变主力

Jan 18 12:05

$Charles River (CRL.US)$ It’s cheap, but no sizable upside without material improvement of the earnings. 140s might be in the cards. Go against the trend is a dangerous thing. Those sitting on a loss have to cut loss given the extreme resistance above. Only improvement of the earnings can save this stock. They also seem to be losing some clients to competitors.

韭菜变主力

Dec 30, 2024 15:18

$Charles River (CRL.US)$ In this almost everything rally market with stocks doubling easily, biomedical research companies have found growth is extremely hard to come by, and P/E has been stuck going nowhere.

Moomoo AI

Feb 29, 2024 15:09

The CEOs of both Wheeler Bio and Charles River express optimism about the partnership, believing that the integration of discovery CRO and CDMO workflows will speed up the path to first-in-human trials and bring new treatments to patients faster.

Press Release: Wheeler Bio Seals Agreement With Charles River to Offer Portable CMC(R) to Discovery Clients to Accelerate Their Journey to First-in-Human Use

Moomoo AI

Feb 26, 2024 18:44

Insider's recent share sale, even below current price, suggests satisfaction with lower valuation. Despite high insider ownership, this selling hints at caution. The company also has 1 warning sign worth noting before buying shares.

Have Charles River Laboratories International Insiders Been Selling Stock?

Moomoo AI

Feb 16, 2024 23:18

EPS growth outshines the yearly share price gain of 12%, indicating market caution towards the stock. Despite sell-off, long term shareholders gained 12% annually over five years, suggesting the sell-off might be a growth opportunity.

Charles River Laboratories International (NYSE:CRL) Stock Performs Better Than Its Underlying Earnings Growth Over Last Five Years